Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: A preliminary report

Giuseppe Di Bella, Fabrizio Mascia, Alessandro Ricchi, Biagio Colori

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: A preliminary report'. Together they form a unique fingerprint.

Medicine & Life Sciences